{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-007400","form_type":"8-K","ticker":"OM","cik":"0001484612","company_name":"Outset Medical, Inc.","filed_at":"2022-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.873637+00:00","generated_at":"2026-06-26T00:36:39.748093+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Outset Medical Q1 revenue $30.6M (+33% YoY); narrows FY2022 guidance to $144M-$150M","bullets":["Revenue $30.6M (+33.3% YoY); product revenue $25.7M (+40.9%).","GAAP gross margin 14.5% vs 1.3% YoY; non-GAAP gross margin 14.8%.","GAAP net loss ($36.9M) or ($0.78)/share; non-GAAP net loss ($31.9M) or ($0.67)/share.","FY2022 revenue guidance narrowed to $144M-$150M (prior $142M-$150M), 40-46% growth.","Appointed Dale E. Jones to Board; cash $335.6M; record Tablo Home console shipments."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-007400","json":"https://secwatch.observer/filing/0000950170-22-007400.json","markdown":"https://secwatch.observer/filing/0000950170-22-007400.md","text":"https://secwatch.observer/filing/0000950170-22-007400.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1484612/000095017022007400/0000950170-22-007400-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1484612/000095017022007400/om-20220504.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T00:36:39.748093+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}